Literature DB >> 3163799

Adenosine deaminase gene expression is regulated posttranscriptionally in the nucleus.

T M Berkvens1, F Schoute, H van Ormondt, P Meera Khan, A J van der Eb.   

Abstract

The housekeeping enzyme adenosine deaminase (ADA) shows a large variation in tissue-specific expression ranging from 1 Iu in red blood cells to 880 Iu in thymocytes. We investigated the acute lymphocytic leukemic cell line Molt-4 (660 Iu ADA/g protein) and the promyelocytic cell line HL-60 (38 Iu ADA/g protein) as a model system to determine the levels at which the tissue-specific expression of ADA is regulated. From our results it can be concluded that the almost 20-fold difference in ADA expression between Molt-4 and HL-60 is the result of differences in the post-transcriptional processing and/or stability of ADA pre-mRNA within the nucleus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3163799      PMCID: PMC336492          DOI: 10.1093/nar/16.8.3255

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  40 in total

1.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

2.  A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells.

Authors:  D L Bentley; M Groudine
Journal:  Nature       Date:  1986 Jun 12-18       Impact factor: 49.962

3.  Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells.

Authors:  R L Friedman; S P Manly; M McMahon; I M Kerr; G R Stark
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

4.  Extreme instability of myc mRNA in normal and transformed human cells.

Authors:  C Dani; J M Blanchard; M Piechaczyk; S El Sabouty; L Marty; P Jeanteur
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

5.  Posttranscriptional mechanisms are responsible for accumulation of truncated c-myc RNAs in murine plasma cell tumors.

Authors:  M Piechaczyk; J Q Yang; J M Blanchard; P Jeanteur; K B Marcu
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

6.  Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency.

Authors:  D T Bonthron; A F Markham; D Ginsburg; S H Orkin
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

7.  Introduction of sequences encoding functional human adenosine deaminase into mouse cells using a retroviral shuttle system.

Authors:  D Valerio; M G Duyvesteyn; A J van der Eb
Journal:  Gene       Date:  1985       Impact factor: 3.688

8.  Cloning of human adenosine deaminase cDNA and expression in mouse cells.

Authors:  D Valerio; R S McIvor; S R Williams; M G Duyvesteyn; H van Ormondt; A J van der Eb; D W Martin
Journal:  Gene       Date:  1984-11       Impact factor: 3.688

9.  Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9.

Authors:  C Dony; M Kessel; P Gruss
Journal:  Nature       Date:  1985 Oct 17-23       Impact factor: 49.962

10.  One adenosine deaminase allele in a patient with severe combined immunodeficiency contains a point mutation abolishing enzyme activity.

Authors:  D Valerio; B M Dekker; M G Duyvesteyn; L van der Voorn; T M Berkvens; H van Ormondt; A J van der Eb
Journal:  EMBO J       Date:  1986-01       Impact factor: 11.598

View more
  4 in total

1.  Cell type-specific transcriptional regulation of the human adenosine deaminase gene.

Authors:  D L Lattier; J C States; J J Hutton; D A Wiginton
Journal:  Nucleic Acids Res       Date:  1989-02-11       Impact factor: 16.971

2.  Cell type-specific mechanisms of regulating expression of the ornithine decarboxylase gene after growth stimulation.

Authors:  M S Abrahamsen; D R Morris
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

3.  Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.

Authors:  Yang Zhou; Jayasimha N Murthy; Dewan Zeng; Luiz Belardinelli; Michael R Blackburn
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

4.  Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.

Authors:  I Santisteban; F X Arredondo-Vega; S Kelly; A Mary; A Fischer; D S Hummell; A Lawton; R U Sorensen; E R Stiehm; L Uribe
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.